Nanobiotix Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,056	143	313	126	254	475
Market Cap Growth	454.83%	-54.17%	147.96%	-50.42%	-46.44%	156.76%
Enterprise Value	1,078	126	345	108	203	500
Last Close Price	21.80	3.02	6.64	3.62	7.31	13.80
PS Ratio	103.92	-19.94	8.64	26.42	96.13	204.34
PB Ratio	-15.31	-2.18	-169.73	-4.66	9.50	6.74
P/TBV Ratio	-	-	-	-	9.50	6.74
EV/Sales Ratio	106.13	-	9.53	22.66	76.63	215.20
Debt / Equity Ratio	-0.74	-0.77	-27.44	-1.97	1.72	0.70
Net Debt / Equity Ratio	-0.32	-0.02	13.41	-0.44	-1.41	-1.00
Net Debt / EBITDA Ratio	-0.51	-0.02	1.04	-0.27	0.83	2.01
Net Debt / FCF Ratio	-0.71	-0.06	1.93	-0.32	1.26	2.54
Asset Turnover	0.15	-	0.47	0.06	0.02	0.02
Quick Ratio	0.58	0.98	1.68	1.23	2.38	6.42
Current Ratio	0.63	1.04	1.75	1.38	2.53	6.58
Return on Equity (ROE)	-	-	-	-	-96.66%	-97.99%
Return on Assets (ROA)	-41.64%	-52.89%	-19.72%	-35.38%	-25.00%	-24.06%
Return on Capital Employed (ROCE)	245.90%	-804.60%	-55.10%	-209.40%	-72.60%	-31.80%
Earnings Yield	-4.89%	-47.53%	-12.69%	-45.21%	-18.47%	-7.07%
FCF Yield	-3.00%	-14.23%	-4.09%	-29.48%	-11.83%	-5.82%
Buyback Yield / Dilution	-10.33%	-27.99%	-5.96%	-0.34%	-42.43%	-12.73%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.